BIO

BIO's 50-day average has risen to $373.00, up from $370.19 10 sessions ago, so the long-term trend check passes. It would flip if that average stopped rising over its 10-session window.

0.8% from failing

BIO has dipped to its 21-day average ($365.42) within the last 3 sessions, so the pullback check passes — the entry sits near support rather than stretched above it. It flips once price goes more than 3 sessions without revisiting that average.

BIO closed at $369.95, 2.0% above its 9-day average ($362.64) — short-term momentum is holding, so this check passes. It flips on a close below $362.64.

2.0% price move from failing (a close below $362.64)

No high-volume gap-down consistent with an earnings miss has appeared in BIO's last 30 sessions, so this check passes. It would flip if such a gap-down showed up inside that window.

A stop under the recent swing low ($347.28) sits 6.1% below BIO's price — inside the 2–8% band, so the risk check passes. It flips if that distance drops under 2% or widens past 8%.

1.9% from failing

The stop sits 1.8× the average daily range (ATR) from price, clearing the 1-ATR minimum, so this check passes — the stop isn't buried inside normal noise. It flips if that room tightens inside 1× ATR.

0.8× a daily range from failing

Recent volume is 0.72× BIO's 20-day average — below the 0.8× threshold, so the pullback looks quiet and this check passes. It flips if volume pushes past 0.8× that average.

0.08× average volume from failing